(2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6R)-6-[(2S,3R,4R,5R)-2-[(1R)-1,2-Dihydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Term ID

CHEBI:153930

Synonyms

alpha-D-galacto-hexopyranosyl-(1->4)-alpha-D-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexofuranose
Gal(a1-4)Gal(a1-3)b-Galf
WURCS=2.0/2,3,2/[a2112h-1b_1-4][a2112h-1a_1-5]/1-2-2/a3-b1_b4-c1

Definition

References

GlyGen:G78082BD
GlyTouCan:G78082BD

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycoside

glycoside Show first 5 Terms

Phenotype

Phenotype resulting from (2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6R)-6-[(2S,3R,4R,5R)-2-[(1R)-1,2-Dihydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype where environments contain (2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6R)-6-[(2S,3R,4R,5R)-2-[(1R)-1,2-Dihydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6R)-6-[(2S,3R,4R,5R)-2-[(1R)-1,2-Dihydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Human Disease Model